Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 1581-1600 of 2,731 trials

Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDs

NCT04286789

This is a randomized, vehicle controlled, double-blind, repeat dose comparative study in patients with rheumatoid arthritis (RA) under management with DMARDs and with persistent disease activity. The goal of this study is to evaluate the safety, tolerability and pharmacokinetics of 6 weekly repeat doses of ORTD-1.

Rheumatoid Arthritis

Oryn Therapeutics, LLC17 participantsStarted Mar 2021

Los Angeles, California, United States • Tustin, California, United States • Miami, Florida, United States

COMPLETEDPhase 1< 1 mile

Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia

NCT02808442

This study aims to evaluate the safety and feasibility of UCART19 to induce molecular remission in pediatric patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (B-ALL).

Refractory B-cell Acute Lymphoblastic LeukemiaRelapsed B-cell Acute Lymphoblastic Leukemia

Institut de Recherches Internationales Servier13 participantsStarted Jun 2016

Los Angeles, California, United States • Philadelphia, Pennsylvania, United States • Dallas, Texas, United States +3 more locations

TERMINATEDNA< 1 mile

Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)

NCT00805948

The purpose of this study is to evaluate the long-term safety and effectiveness of the Talent Thoracic Stent Graft System for treatment of descending thoracic aneurysms (DTA)following U.S. market approval.

Thoracic Aortic Aneurysms

Medtronic Cardiovascular349 participantsStarted Apr 2009

Los Angeles, California, United States • Torrance, California, United States • Washington D.C., District of Columbia, United States +23 more locations

Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDs

Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia

Post-Approval Clinical Study of the Talent Thoracic Stent Graft to Treat Thoracic Aortic Aneurysms (THRIVE)

Rheumatoid Arthritis Trials in Other Cities

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

OptiMesh® for Lumbar Interbody Fusion Trial (OLIF)

Bringing Relief to Adolescents Naturally Using Melatonin for Migraine

Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis

Text Messages for Liver Transplant Recipients

An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)

Impact of Acthar on Everyday Life of Participants With Severe Keratitis

An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults

A Study of MPT-0118 in Subjects With Advanced or Metastatic Refractory Solid Tumors

FST-100 Ophthalmic Suspension in Acute Adenoviral Conjunctivitis

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

A Cross-Sectional Study to Assess Walking Performance in Subjects With Peripheral Artery and End Stage Kidney Disease

A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

Post-market Study to Obtain Surgeon Feedback on Clinical Outcome in Eyes Implanted With TECNIS Toric II IOL

Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers

A Cohort Study of Operationally Tolerant Allograft Recipients

Phase 4, Controlled Study in Adult Subjects Undergoing Primary, 1-2 Level, Open Lumbar Spinal Fusion Surgery

Other Conditions in Los Angeles